Literature DB >> 6984061

Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens.

W E Biddison, P E Rao, M A Talle, G Goldstein, S Shaw.   

Abstract

A recently described HLA gene, SB, which maps between GLO and HLA-DR, codes for Ia-like molecules that are similar to but distinct from HLA-DR molecules. Cytotoxic T lymphocytes (CTL) specific for SB1, SB2, SB3, and SB4 were compared with HLA-A2-specific CTL with respect to their surface expression of the T cell differentiation antigens OKT3, OKT4, and OKT8. All CTL activity was eliminated by treatment with OKT3 and C'. The SB-specific cytotoxicity was eliminated by OKT4 plus C' but not by OKT8 plus C'. In contrast, HLA-A2-specific killing was completely susceptible to treatment with OKT8 plus C' but not with OKT4 plus C'. Cytotoxicity was analyzed in the presence of OKT8 and a series of monoclonal antibodies (OKT4A, 4B, 4C, and 4D) that react with distinct epitopes on the OKT4 molecule. SB1-, SB3-, and SB4-specific CTL were partially inhibited by OKT4A and 4B (45-75%), whereas HLA-A2-specific CTL were partially inhibited by OKT8 (48-63%) but not by OKT4. SB2-specific CTL were not inhibited (less than 26%) by OKT8 or by any of the OKT4-related antibodies. These results suggest that the OKT4 marker may be expressed on most T cells that recognize allogeneic Ia or self Ia plus foreign antigens; OKT4+ cells do not appear to be functionally homogeneous in that they can act both as helper/inducer and cytotoxic cells. Models are proposed for the functional involvement of the OKT4 molecule in T cell-Ia antigen interactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984061      PMCID: PMC2186824          DOI: 10.1084/jem.156.4.1065

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Helper cells activated by allogeneic H-2K or H-2D differences have a Ly phenotype distinct from those responsive to I differences.

Authors:  S L Swain; P R Panfili
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

3.  SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines.

Authors:  P Kavathas; R DeMars; F H Bach; S Shaw
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

4.  Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO.

Authors:  S Shaw; P Kavathas; M S Pollack; D Charmot; C Mawas
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

5.  Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens.

Authors:  S Shaw; D L Nelson; G M Shearer
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

6.  Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.

Authors:  E Nakayama; H Shiku; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

Authors:  R Sutherland; D Delia; C Schneider; R Newman; J Kemshead; M Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

8.  Regulation of influenza virus-specific cytotoxic T cell responses by monoclonal antibody to a human T cell differentiation antigen.

Authors:  W E Biddison; G M Shearer; T W Chang
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

9.  Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.

Authors:  N Shinohara; D H Sachs
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

10.  Surface markers of cloned human T cells with various cytolytic activities.

Authors:  L Moretta; M C Mingari; P R Sekaly; A Moretta; B Chapuis; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  78 in total

Review 1.  The human T-cell receptor.

Authors:  O Acuto; M Fabbi; A Bensussan; C Milanese; T J Campen; H D Royer; E L Reinherz
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

Review 2.  The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation.

Authors:  J Auwerx
Journal:  Experientia       Date:  1991-01-15

3.  Cytotoxic T cells against herpes simplex virus in Behçet's disease.

Authors:  K Hamzaoui; A Kahan; K Ayed; M Hamza
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

4.  CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.

Authors:  F Andris; O Leo; M Van Mechelen; J Urbain; M Slaoui
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

Review 5.  T-cell clones and T-cell receptors.

Authors:  F W Fitch
Journal:  Microbiol Rev       Date:  1986-03

6.  Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides.

Authors:  Y Hayashi; K Ikuta; N Fujii; K Ezawa; S Kato
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 7.  CD4 on the road to coreceptor status.

Authors:  Dario A A Vignali
Journal:  J Immunol       Date:  2010-06-01       Impact factor: 5.422

Review 8.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

9.  Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

Authors:  T A Waldmann; W C Greene; P S Sarin; C Saxinger; D W Blayney; W A Blattner; C K Goldman; K Bongiovanni; S Sharrow; J M Depper
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Evaluation of anti-human immunodeficiency virus effect of recombinant CD4-immunoglobulin in vitro: a good candidate for AIDS treatment.

Authors:  I H Chowdhury; Y Koyanagi; K Takamatsu; O Yoshida; S Kobayashi; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.